Human LILRB2 / CD85d / ILT4 Protein, Fc Tag (MALS verified), Unconjugated

Artikelnummer: ABS-LI2-H5253-1MG
Artikelname: Human LILRB2 / CD85d / ILT4 Protein, Fc Tag (MALS verified), Unconjugated
Artikelnummer: ABS-LI2-H5253-1MG
Hersteller Artikelnummer: LI2-H5253-1mg
Alternativnummer: ABS-LI2-H5253-1MG
Hersteller: AcroBiosystems
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Konjugation: Unconjugated
Leukocyte immunoglobulinlike receptor subfamily B member 2 (LILRB2) is also known as CD85 antigenlike family member D (CD85d), Immunoglobulinlike transcript 4 (ILT4), Monocyte / macrophage immunoglobulinlike receptor 10 (MIR10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLAA, HLAB, HLAC and HLAG alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1Amediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions. - Proteine/Peptide
Molekulargewicht: 74.2 kDa
Tag: C-Fc
NCBI: 36827
Puffer: 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5
Reinheit: 90%
Formulierung: Powder
Target-Kategorie: LILRB2
Immobilized Human LILRB2, Fc Tag (Cat. No. LI2-H5253) at 1 µg/mL (100 µL/well) can bind Anti-LILRB2Antibody,HumanIgG1 with a linear range of 0.2-2 ng/mL (QC tested).
Serial dilutions of Monoclonal Anti-LILRB2 Antibody, Human IgG1 were added into Human LILRB2, Fc Tag (Cat. No. LI2-H5253) : Biotinylated Human HLA-G&B2M&Peptide (RIIPRHLQL) Tetramer Protein, His,Avitag (Cat. No. HLG-H52E9) binding reactions. The half maximal inhibitory concentration (IC50) is 0.70 µg/mL (Routinely tested).
Human LILRB2, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.